Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study
Dimitrios A. PappasColumbia University College of Physicians and Surgeons, New York, NY, USA. [email protected]Fredrik NybergMedical Evidence and Observational Research Centre, Global Medicines Development, AstraZeneca R&D, Mölndal, SwedenJoel M. KremerAlbany Medical College and The Center for Rheumatology, Albany, NY, USAKathy LamplGeorge ReedCorrona LLC, Southborough, MA, USALaura HorneMedical Evidence and Observational Research Centre, Global Medicines Development, AstraZeneca R&D, Wilmington, DE, USAMeilien HoClinical, Global Medicines Development, AstraZeneca R&D, Alderley Park, UKAlina OnofreiAnand N. MalaviyaOscar RilloS. RadominskiUniversidade Federal do Paraná and CETI, Curitiba, BrazilJános GálAllan GibofskyHospital for Special Surgery-Weill Medical College of Cornell University, Ithaca, New York, USAТ. В. ПопковаNasonova Research Institute of Rheumatology, Moscow, RussiaLeda LaurindoUniversity Nove De Julho, São Paulo, BrazilEduardo KerzbergJM Ramos Mejía Hospital, School of Medicine, University of Buenos Aires, Buenos Aires, ArgentinaR. ZahoraRevmatologická Ambulance, Terezín, Czech RepublicBernardo A. Pons‐EstelCardiovascular Institute of Rosario, Rosario, ArgentinaJeffrey R. CurtisUniversity of Alabama at Birmingham, Birmingham, AL, USADaniel E. FurstDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USAJeffrey D. GreenbergCorrona LLC, Southborough, MA, USA
2018en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0